City of Huntington, West Virginia et al v. AmerisourceBergen Drug Corporation et al
Case Number:
3:17-cv-01362
Court:
Nature of Suit:
Judge:
Firms
- Bailey & Glasser
- Bailey & Wyant
- Baker Sterchi
- Baron & Budd
- Bartlit Beck
- Bowles Rice
- Covington & Burling
- Dykema
- Farrell & Fuller
- Fitzsimmons Law Firm
- Flaherty Sensabaugh
- Greene Ketchum
- Hill Peterson Carper
- Irpino Avin
- Jenkins Fenstermaker
- Jones Day
- Keller Rohrback
- Kobre & Kim
- Lamp Bartram
- Lanier Law Firm
- Levin Papantonio
- Lewis Gianola
- Lieff Cabraser
- McHugh Fuller
- Morgan Lewis
- Motley Rice
- Powell & Majestro
- Reed Smith
- Seeger Weiss
- Simmons Hanly
- Spilman Thomas
- Stites & Harbison
- Theisen Brock
- Thomas Combs
- UB Greensfelder
- Weisman Kennedy
- Williams & Connolly
- Zuckerman Spaeder
Companies
- Allergan PLC
- Amneal Pharmaceuticals Inc.
- Cabell Huntington Hospital
- Cardinal Health Inc.
- Cencora Inc.
- Cephalon Inc.
- CVS Health Corp.
- Endo International PLC
- Express Scripts Holding Co.
- H.D. Smith LLC
- Impax Laboratories, Inc.
- Johnson & Johnson
- KVK Tech Inc.
- Mallinckrodt PLC
- McKesson Corp.
- Noramco Inc.
- Par Pharmaceutical Cos. Inc.
- Purdue Pharma LP
- Rite Aid Corp.
- Teva Pharmaceutical Industries Ltd.
- The Cigna Group
- The Kroger Co.
- Walgreens Boots Alliance Inc.
- Walmart Inc.
- Warner Chilcott Limited
Government Agencies
- Federal Bureau of Investigation
- U.S. Drug Enforcement Administration
- West Virginia Attorney General's Office
- West Virginia Department of Health & Human Resources
- West Virginia Offices of the Insurance Commissioner
Sectors & Industries:
-
March 18, 2024
4th Circ. Sends Opioid 'Nuisance' Question To W.Va. Top Court
The Fourth Circuit asked West Virginia's high court Monday to determine whether the state's public nuisance law can be used to target companies that shipped drugs to pharmacies in a community ravaged by addiction, a crucial question in litigation spawned by the opioid crisis.
-
January 25, 2024
Opioid Nuisance Query Better For W.Va. Court, 4th Circ. Hints
A Fourth Circuit panel asked repeatedly Thursday why no one had sought help from West Virginia's high court in a bellwether legal clash over whether anti-nuisance laws can be used to target the drug companies that supplied pharmacies amid the opioid crisis.
-
May 02, 2023
Reject 'Carte Blanche' For Risky Opioid Sales, 4th Circ. Urged
A West Virginia city and county have told the Fourth Circuit that distributors of addictive painkillers misinterpreted state nuisance law and the federal Controlled Substances Act when seeking to uphold a lower court's dismissal of the local governments' multibillion-dollar opioid lawsuit.
-
March 24, 2023
Opioid Theory Reaches 'Alcohol, Guns, Phones,' 4th Circ. Told
A West Virginia federal judge's monumental rejection of a multibillion-dollar opioid case correctly avoided a "dramatic rewriting" of state law that would threaten legal exposure for sellers of liquor, cellphones, firearms and other lawful products, drug distributors told the Fourth Circuit on Friday.
-
January 03, 2023
Health & Pharma Legal Clashes Didn't Take A Holiday Break
While many Americans were bringing glad tidings and popping bubbly, attorneys spent the final week of 2022 bringing lawsuits, appeals and other court filings of eye-popping significance for health care providers and drug companies in cases involving the False Claims Act, the opioid crisis and purported price-fixing schemes.
-
August 05, 2022
Landmark Opioid Opinion 'Not Persuasive,' W.Va. Panel Says
A West Virginia federal judge contravened long-standing precedent when he sided with drug distributors last month after a major opioid crisis trial, the Mountain State's Mass Litigation Panel said in a ruling against national pharmacy chains that are approaching a similar trial.
-
August 02, 2022
W.Va. County Appeals Opioid Bellwether Ruling
A West Virginia county on Tuesday said it was appealing a verdict in favor of the nation's three largest drug distributors in the first federal bellwether trial over the opioid crisis, a day after the companies inked a $400 million deal to end similar claims from other cities in the state.
-
July 25, 2022
How Reed Smith Notched A 'Sweeping' Opioid Trial Triumph
One of America's largest distributors of prescription opioids went on trial in an epicenter of opioid abuse and emerged victorious this month by deploying a legal strategy that melded compassion and confidence, the company's lead counsel at Reed Smith LLP told Law360 in an interview.
-
July 19, 2022
Top Product Liability Cases Of 2022: Midyear Review
Major product liability cases so far in 2022 include a ruling in West Virginia against local governments seeking relief from drug distributors for the opioid crisis and a historic settlement with gunmaker Remington to end claims brought by the families of Sandy Hook victims. Here, Law360 looks at key cases from the first half of the year.
-
July 08, 2022
W.Va. Opioid Verdict Widens Judge-Jury Split On Vital Theory
A resounding victory by drug distributors in a bench trial over West Virginia's catastrophic opioid crisis underscores a growing gulf between judges and juries in broader opioid litigation, with judges increasingly rejecting a crucial legal theory while juries embrace it.